In accordance with Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended on March 31, 2024, based on the certificate received from Beetal Financial & Computer Services (RTA) dated 05/04/2024, which is enclosed, Titan Biotech has forwarded the same.
The above information is a part of company’s filings submitted to BSE.